These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

311 related articles for article (PubMed ID: 32258519)

  • 1. Ablative therapies for hepatic and biliary tumors: endohepatology coming of age.
    Satiya J; Schwartz I; Tabibian JH; Kumar V; Girotra M
    Transl Gastroenterol Hepatol; 2020; 5():15. PubMed ID: 32258519
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Radiofrequency ablation in the management of primary hepatic and biliary tumors.
    Hendriquez R; Keihanian T; Goyal J; Abraham RR; Mishra R; Girotra M
    World J Gastrointest Oncol; 2022 Jan; 14(1):203-215. PubMed ID: 35116111
    [TBL] [Abstract][Full Text] [Related]  

  • 3. ERCP-directed radiofrequency ablation and photodynamic therapy are associated with comparable survival in the treatment of unresectable cholangiocarcinoma.
    Strand DS; Cosgrove ND; Patrie JT; Cox DG; Bauer TW; Adams RB; Mann JA; Sauer BG; Shami VM; Wang AY
    Gastrointest Endosc; 2014 Nov; 80(5):794-804. PubMed ID: 24836747
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Advances in endoscopic retrograde cholangiopancreatography for the treatment of cholangiocarcinoma.
    Uppal DS; Wang AY
    World J Gastrointest Endosc; 2015 Jun; 7(7):675-87. PubMed ID: 26140095
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Insufficient ablative margin determined by early computed tomography may predict the recurrence of hepatocellular carcinoma after radiofrequency ablation.
    Teng W; Liu KW; Lin CC; Jeng WJ; Chen WT; Sheen IS; Lin CY; Lin SM
    Liver Cancer; 2015 Mar; 4(1):26-38. PubMed ID: 26020027
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Biliary Tumor Ablation with Photodynamic Therapy and Radiofrequency Ablation.
    Smith I; Kahaleh M
    Gastrointest Endosc Clin N Am; 2015 Oct; 25(4):793-804. PubMed ID: 26431605
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Locoregional Treatments in Cholangiocarcinoma and Combined Hepatocellular Cholangiocarcinoma.
    Renzulli M; Ramai D; Singh J; Sinha S; Brandi N; Ierardi AM; Albertini E; Sacco R; Facciorusso A; Golfieri R
    Cancers (Basel); 2021 Jul; 13(13):. PubMed ID: 34283065
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The current role of radiofrequency ablation in the management of hepatocellular carcinoma: a systematic review.
    Lau WY; Lai EC
    Ann Surg; 2009 Jan; 249(1):20-5. PubMed ID: 19106671
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Endoscopic ablation therapy for biliopancreatic malignancies.
    Roque J; Ho SH; Reddy N; Goh KL
    Clin Endosc; 2015 Jan; 48(1):15-9. PubMed ID: 25674521
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Image-guided, minimally invasive surgery and other local therapeutic procedures for primary liver tumors].
    Stippel DL; Wahba R; Bruns CJ; Bunck A; Baues C; Persigehl T
    Chirurg; 2018 Nov; 89(11):872-879. PubMed ID: 30030546
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Bile Duct Patency Maintained after Intraductal Radiofrequency Ablation in a Case of Hepatocellular Cholangiocarcinoma with Bile Duct Invasion.
    Han SY; Song GA; Kim DU; Baek DH; Lee MW; Kim GH
    Clin Endosc; 2018 Mar; 51(2):201-205. PubMed ID: 28854773
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Role of local ablative therapy for hepatocellular carcinoma.
    Thandassery RB; Goenka U; Goenka MK
    J Clin Exp Hepatol; 2014 Aug; 4(Suppl 3):S104-11. PubMed ID: 25755601
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Local ablative therapies in HCC: percutaneous ethanol injection and radiofrequency ablation.
    Mahnken AH; Bruners P; Günther RW
    Dig Dis; 2009; 27(2):148-56. PubMed ID: 19546553
    [TBL] [Abstract][Full Text] [Related]  

  • 14. State of the ablation nation: a review of ablative therapies for cure in the treatment of hepatocellular carcinoma.
    Salati U; Barry A; Chou FY; Ma R; Liu DM
    Future Oncol; 2017 Jul; 13(16):1437-1448. PubMed ID: 28685607
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The minimal ablative margin of radiofrequency ablation of hepatocellular carcinoma (> 2 and < 5 cm) needed to prevent local tumor progression: 3D quantitative assessment using CT image fusion.
    Kim YS; Lee WJ; Rhim H; Lim HK; Choi D; Lee JY
    AJR Am J Roentgenol; 2010 Sep; 195(3):758-65. PubMed ID: 20729457
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Outcome of regional and local ablative therapies for hepatocellular carcinoma: a collective review.
    Jansen MC; van Hillegersberg R; Chamuleau RA; van Delden OM; Gouma DJ; van Gulik TM
    Eur J Surg Oncol; 2005 May; 31(4):331-47. PubMed ID: 15837037
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Short-term effects and adverse events of endoscopically applied radiofrequency ablation appear to be comparable with photodynamic therapy in hilar cholangiocarcinoma.
    Schmidt A; Bloechinger M; Weber A; Siveke J; von Delius S; Prinz C; Schmitt W; Schmid RM; Neu B
    United European Gastroenterol J; 2016 Aug; 4(4):570-9. PubMed ID: 27536367
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Feasibility and outcomes of percutaneous thermal ablation of hepatocellular carcinoma in a transplanted allograft.
    Welch BT; Schmitz JJ; Kurup AN; Atwell TD; Callstrom MR; Frey G; Paz-Fumagalli R; Allen A; Watt K; Heimbach J; Schmit GD
    Abdom Radiol (NY); 2018 Jun; 43(6):1478-1481. PubMed ID: 28936550
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Experience with more than 500 minimally invasive hepatic procedures.
    Buell JF; Thomas MT; Rudich S; Marvin M; Nagubandi R; Ravindra KV; Brock G; McMasters KM
    Ann Surg; 2008 Sep; 248(3):475-86. PubMed ID: 18791368
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Long term (5 years) outcome of radiofrequency ablation for hepatocellular carcinoma in 256 cases].
    Chen MH; Yan K; Yang W; Gao W; Dai Y; Huo L; Zhang H; Huang XF
    Beijing Da Xue Xue Bao Yi Xue Ban; 2005 Dec; 37(6):671-2. PubMed ID: 16378128
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.